Tyra Biosciences Inc
(TYRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TYRA | AZN | AMGN | GILD | VRTX |
| Company | Tyra Biosciences Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 30.31 | 187.07 | 365.73 | 146.50 | 473.90 |
| High | 31.27 | 190.67 | 374.90 | 150.50 | 478.00 |
| Low | 29.39 | 186.58 | 365.00 | 145.87 | 457.74 |
| Latest | 29.46 | 187.16 | 367.80 | 149.37 | 458.81 |
| Change | -1.31 | -0.29 | +1.60 | +3.14 | -11.71 |
| % Change | -4.26% | -0.15% | +0.44% | +2.15% | -2.49% |
| Volume | 625,448 | 3,375,291 | 3,983,280 | 9,122,465 | 1,669,687 |
| 20-Day Average Volume | 643,832 | 8,960,856 | 2,961,798 | 7,909,931 | 1,464,915 |
| Previous Close | 30.77 | 187.45 | 366.20 | 146.23 | 470.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.15 | 112.14 | 340.23 | 132.90 | 462.93 |
| 20-Day Raw Stochastic | 46.43% | 94.93% | 82.33% | 94.75% | 51.88% |
| 20-Day Relative Strength | 58.68 | 88.35 | 65.31 | 74.69 | 50.12 |
| Weighted Alpha | +164.55 | +68.67 | +31.88 | +60.85 | +1.92 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | 40% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.04% since 01/29/26 | +102.54% since 01/29/26 | +6.48% since 01/29/26 | +6.68% since 01/29/26 | -3.63% since 01/29/26 |
| Low | 29.51 on 02/04/26 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 138.65 on 01/30/26 | 457.74 on 02/05/26 |
| High | 32.37 on 02/03/26 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 478.72 on 02/04/26 |
| 1-Month | |||||
| %Chg | +13.12% since 01/05/26 | +105.59% since 01/05/26 | +13.86% since 01/05/26 | +25.84% since 01/05/26 | +2.14% since 01/05/26 |
| Low | 25.88 on 01/06/26 | 89.04 on 01/21/26 | 318.83 on 01/06/26 | 118.22 on 01/06/26 | 429.00 on 01/20/26 |
| High | 32.44 on 01/27/26 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +100.67% since 11/05/25 | +131.10% since 11/05/25 | +14.16% since 11/05/25 | +21.44% since 11/05/25 | +9.93% since 11/05/25 |
| Low | 13.35 on 11/06/25 | 83.37 on 11/06/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 406.67 on 11/07/25 |
| High | 32.44 on 01/27/26 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +159.74% since 08/05/25 | +151.79% since 08/05/25 | +21.69% since 08/05/25 | +32.37% since 08/05/25 | +22.25% since 08/05/25 |
| Low | 9.96 on 08/20/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 32.44 on 01/27/26 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,642,257 | 290,717,696 | 197,191,760 | 181,424,640 | 119,379,856 |
| Shares Outstanding, K | 53,372 | 1,550,908 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -86,480,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -29,870,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.07 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/05/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/10/26 | 05/07/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.17 | 15.50 | 17.49 | 30.41 |